Pembrolizumab

Keytruda

Treatment Description

One way your immune system controls the activity of T cells is through the PD-1 pathway. Some cancer cells can hide from the T cells attack by taking control of the PD-1 pathway. This stops T cells from attacking cancer cells. Pembrolizumab works by blocking the PD-1 pathway.

Participating Centers

There are 19 centers running trials with this treatment. Enter a location below to find the closest center.